Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Qiagen has launched a new molecular diagnostic test to type the HLA-B5701 allele, a genetic variation in the human leucocyte antigen system.
Subscribe to our email newsletter
The newly launched test complements a larger personalized medicine portfolio which includes, subject to regulatory approval in various countries, molecular tests related to transplantation, cancer and other therapies.
The new Olerup SSPO PCR assay was developed and manufactured by Olerup SSP. It is CE marked in Europe for in vitro diagnostic use and available for research use in other countries.
Peer Schatz, CEO of Qiagen, said: “Our new test is another great example for the advent of molecular diagnostic tests, which can be used to assess the efficacy of drugs.”